Trial intelligence / Profile preview

bIAP in Acute Rheumatoid Arthritis

NCT01416493Phase 2Completed

Sponsor
Alloksys Life Sciences
Start
May 2011
Primary completion
Apr 2013
Modality
Replacement Enzymes
Countries
1
01

Overview

A Phase 2 trial of bovine intestinal alkaline phosphatase in rheumatoid arthritis (RA), sponsored by Alloksys Life Sciences. Started May 2011; status: completed.

02

Drugs

bovine intestinal alkaline phosphatase
03

Conditions

rheumatoid arthritis (RA)

Beyond the preview

Go deeper on NCT01416493.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01416493.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call